XPH icon

SPDR S&P Pharmaceuticals ETF
XPH

Overview Fund Activity

73 hedge funds and large institutions have $117M invested in SPDR S&P Pharmaceuticals ETF in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 15 closing their positions.

Holders
73
Holders Change
+6
Holders Change %
+8.96%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
20
Reduced
17
Closed
15
Calls
$3.33M
Puts
$335K
Net Calls
+$3M
Net Calls Change
-$369K

Top Buyers

1
Commonwealth Equity Services
1
Commonwealth Equity Services
Massachusetts
$3.74M
2
CI
2
CX Institutional
Indiana
$1.74M
3
Ameriprise
3
Ameriprise
Minnesota
$1.4M
4
CS
4
Credit Suisse
Switzerland
$1.19M
5
LPL Financial
5
LPL Financial
California
$3M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$18.9M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$17.6M
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
BCM
4
Brookstone Capital Management
Illinois
$2.16M
5
Goldman Sachs
5
Goldman Sachs
New York
$25.9M
Name Market Value Shares Shares
Change 		Shares
Change %
SC
76
Scotia Capital
Ontario, Canada
– – -10,512 Closed
NAS
77
Nicolet Advisory Services
Wisconsin
– – -9,846 Closed
AWM
78
AE Wealth Management
Kansas
– – -7,284 Closed
SS
79
Simplicity Solutions
Minnesota
– – -7,237 Closed
OLA
80
Oliver Luxxe Assets
New Jersey
– – -5,820 Closed
BFC
81
Bedel Financial Consulting
Indiana
– – -2,505 Closed
HIIFS
82
Harel Insurance Investments & Financial Services
Israel
– – -1,400 Closed
AA
83
Advisory Alpha
Michigan
– – -1,085 Closed
William Blair & Company
84
William Blair & Company
Illinois
– – -532 Closed
AP
85
Advisors Preferred
Maryland
– – -218 Closed
WQ
86
Wealth Quarterback
New Jersey
– – -202 Closed
NFG
87
Next Financial Group
Texas
– – -160 Closed
HNB
88
Huntington National Bank
Ohio
– – – –
RIM
89
Rockbridge Investment Management
New York
$0 10 +10 New
1 2 3
4